Amgen
IMLYGIC
Manufacturer:
Amgen
Name:
IMLYGIC
HCPCS Code Descriptor:
Injection, talimogene laherparepvec, per 1 million plaque forming units
Category:
J Code
HCPCS:
J9325
NDC(s):
55513-0078-01, 55513-0079-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Injection
About:
IMLYGIC is an Oncology drug manufactured by Amgen and administered via the Injection route of administration. The J Code: J9325 is aligned to the drug IMLYGIC.